| Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo … D Gabrilovich, T Ishida, T Oyama, S Ran, V Kravtsov, S Nadaf, ... Blood, The Journal of the American Society of Hematology 92 (11), 4150-4166, 1998 | 1255 | 1998 |
| Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hemopoietic progenitor cells T Oyama, S Ran, T Ishida, S Nadaf, L Kerr, DP Carbone, DI Gabrilovich The Journal of Immunology 160 (3), 1224-1232, 1998 | 724 | 1998 |
| Increased exposure of anionic phospholipids on the surface of tumor blood vessels S Ran, A Downes, PE Thorpe Cancer research 62 (21), 6132-6140, 2002 | 620 | 2002 |
| Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer C Mehner, A Hockla, E Miller, S Ran, DC Radisky, ES Radisky Oncotarget 5 (9), 2736, 2014 | 409 | 2014 |
| Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy S Ran, PE Thorpe International Journal of Radiation Oncology* Biology* Physics 54 (5), 1479-1484, 2002 | 333 | 2002 |
| Lymphangiogenesis and lymphatic metastasis in breast cancer S Ran, L Volk, K Hall, MJ Flister Pathophysiology 17 (4), 229-251, 2010 | 322 | 2010 |
| Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse Y Weinstein, S Ran, S Segal The Journal of Immunology 132 (2), 656-661, 1984 | 303 | 1984 |
| Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect E Castro-Rivera, S Ran, P Thorpe, JD Minna Proceedings of the National Academy of Sciences 101 (31), 11432-11437, 2004 | 251 | 2004 |
| Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression S Bandyopadhyay, SK Pai, S Hirota, S Hosobe, Y Takano, K Saito, ... Oncogene 23 (33), 5675-5681, 2004 | 243 | 2004 |
| Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-κB and Prox1 MJ Flister, A Wilber, KL Hall, C Iwata, K Miyazono, RE Nisato, MS Pepper, ... Blood, The Journal of the American Society of Hematology 115 (2), 418-429, 2010 | 240 | 2010 |
| Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner L Volk-Draper, K Hall, C Griggs, S Rajput, P Kohio, D DeNardo, S Ran Cancer research 74 (19), 5421-5434, 2014 | 238 | 2014 |
| Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature S Ran, B Gao, S Duffy, L Watkins, N Rote, PE Thorpe Cancer research 58 (20), 4646-4653, 1998 | 206 | 1998 |
| WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway S Yoshioka, ML King, S Ran, H Okuda, JA MacLean, ME McAsey, ... Molecular Cancer Research 10 (3), 469-482, 2012 | 193 | 2012 |
| Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice S Ran, J He, X Huang, M Soares, D Scothorn, PE Thorpe Clinical cancer research 11 (4), 1551-1562, 2005 | 186 | 2005 |
| In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors LM Veenendaal, H Jin, S Ran, L Cheung, N Navone, JW Marks, ... Proceedings of the National Academy of Sciences 99 (12), 7866-7871, 2002 | 182 | 2002 |
| A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model W Zhang, S Ran, M Sambade, X Huang, PE Thorpe Angiogenesis 5, 35-44, 2002 | 154 | 2002 |
| TLR4 is a novel determinant of the response to paclitaxel in breast cancer S Rajput, LD Volk-Draper, S Ran Molecular cancer therapeutics 12 (8), 1676-1687, 2013 | 152 | 2013 |
| Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors S Ran, KE Montgomery Cancers 4 (3), 618-657, 2012 | 140 | 2012 |
| The role of TLR4 in chemotherapy-driven metastasis S Ran Cancer research 75 (12), 2405-2410, 2015 | 117 | 2015 |
| Anti‐VEGF‐A therapy reduces lymphatic vessel density and expression of VEGFR‐3 in an orthotopic breast tumor model B Whitehurst, MJ Flister, J Bagaitkar, L Volk, CM Bivens, B Pickett, ... International Journal of Cancer 121 (10), 2181-2191, 2007 | 115 | 2007 |
Michael J FlisterDirector, ADC Discovery Research at Pfizer OncologyBestätigte E-Mail-Adresse bei pfizer.com
